HRP20040495A2 - Substituted cyclohexane derivatives - Google Patents
Substituted cyclohexane derivatives Download PDFInfo
- Publication number
- HRP20040495A2 HRP20040495A2 HR20040495A HRP20040495A HRP20040495A2 HR P20040495 A2 HRP20040495 A2 HR P20040495A2 HR 20040495 A HR20040495 A HR 20040495A HR P20040495 A HRP20040495 A HR P20040495A HR P20040495 A2 HRP20040495 A2 HR P20040495A2
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- trans
- ethyl
- cyclohexylmethyl
- trifluoromethyl
- Prior art date
Links
- 125000000113 cyclohexyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 title description 4
- -1 A10 lower-alkyl Chemical group 0.000 claims description 270
- 150000001875 compounds Chemical class 0.000 claims description 152
- 238000000034 method Methods 0.000 claims description 102
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical group CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 72
- 238000011282 treatment Methods 0.000 claims description 41
- 239000001257 hydrogen Substances 0.000 claims description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims description 37
- 238000006243 chemical reaction Methods 0.000 claims description 34
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 31
- 150000002148 esters Chemical class 0.000 claims description 31
- 125000000217 alkyl group Chemical group 0.000 claims description 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 25
- 238000011321 prophylaxis Methods 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 20
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 16
- 208000035150 Hypercholesterolemia Diseases 0.000 claims description 15
- 201000010099 disease Diseases 0.000 claims description 14
- 201000005577 familial hyperlipidemia Diseases 0.000 claims description 14
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 claims description 12
- 230000003463 hyperproliferative effect Effects 0.000 claims description 12
- 229910052760 oxygen Inorganic materials 0.000 claims description 12
- 229910052717 sulfur Inorganic materials 0.000 claims description 11
- 206010012601 diabetes mellitus Diseases 0.000 claims description 10
- 125000001072 heteroaryl group Chemical group 0.000 claims description 10
- 208000019553 vascular disease Diseases 0.000 claims description 10
- 208000030852 Parasitic disease Diseases 0.000 claims description 9
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 201000001883 cholelithiasis Diseases 0.000 claims description 9
- 208000001130 gallstones Diseases 0.000 claims description 9
- 229910052740 iodine Inorganic materials 0.000 claims description 9
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 8
- 208000002705 Glucose Intolerance Diseases 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 8
- 229910052794 bromium Inorganic materials 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 201000009104 prediabetes syndrome Diseases 0.000 claims description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical group CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 208000031888 Mycoses Diseases 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical group [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims description 6
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- FVKXSTJUVXDMTK-HAQNSBGRSA-N CN(C)C[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound CN(C)C[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C FVKXSTJUVXDMTK-HAQNSBGRSA-N 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- JVXUYERWXXLADI-WGSAOQKQSA-N CCN(CCO)CCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CCO)CCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 JVXUYERWXXLADI-WGSAOQKQSA-N 0.000 claims description 3
- VQUKKGYYSYBJSD-IYARVYRRSA-N CN(C[C@H]1CC[C@H](CCN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F VQUKKGYYSYBJSD-IYARVYRRSA-N 0.000 claims description 3
- XUDQQWLQROXXBA-WGSAOQKQSA-N CN(C[C@H]1CC[C@H](CCN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F XUDQQWLQROXXBA-WGSAOQKQSA-N 0.000 claims description 3
- JEXKBCZRAJYCQS-QAQDUYKDSA-N CNC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2cccc3ccccc23)CC1 Chemical compound CNC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2cccc3ccccc23)CC1 JEXKBCZRAJYCQS-QAQDUYKDSA-N 0.000 claims description 3
- 206010017533 Fungal infection Diseases 0.000 claims description 3
- 150000001721 carbon Chemical group 0.000 claims description 3
- 208000024386 fungal infectious disease Diseases 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 2
- 229910052770 Uranium Inorganic materials 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 229910052720 vanadium Inorganic materials 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 323
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 174
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 126
- 239000003921 oil Substances 0.000 description 95
- 235000019198 oils Nutrition 0.000 description 95
- 239000000243 solution Substances 0.000 description 95
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 87
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 82
- 239000000203 mixture Substances 0.000 description 75
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 74
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 74
- 239000011541 reaction mixture Substances 0.000 description 73
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 63
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 62
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 59
- 230000002829 reductive effect Effects 0.000 description 59
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 52
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 50
- 239000007787 solid Substances 0.000 description 48
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 47
- 229940098779 methanesulfonic acid Drugs 0.000 description 45
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 44
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
- 239000000741 silica gel Substances 0.000 description 38
- 229910002027 silica gel Inorganic materials 0.000 description 38
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 37
- 235000019341 magnesium sulphate Nutrition 0.000 description 37
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 36
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 36
- 239000003480 eluent Substances 0.000 description 34
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 33
- 239000002904 solvent Substances 0.000 description 32
- 239000012071 phase Substances 0.000 description 27
- 125000004432 carbon atom Chemical group C* 0.000 description 24
- 238000003756 stirring Methods 0.000 description 23
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 22
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 22
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 22
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 22
- 239000002244 precipitate Substances 0.000 description 22
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 21
- 150000003335 secondary amines Chemical class 0.000 description 21
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 20
- 235000019439 ethyl acetate Nutrition 0.000 description 20
- 108010059597 Lanosterol synthase Proteins 0.000 description 19
- 230000006870 function Effects 0.000 description 19
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- 235000011121 sodium hydroxide Nutrition 0.000 description 18
- 150000003840 hydrochlorides Chemical class 0.000 description 17
- 238000010992 reflux Methods 0.000 description 16
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 15
- 239000002253 acid Substances 0.000 description 15
- 150000003141 primary amines Chemical class 0.000 description 15
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 14
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 14
- 150000001412 amines Chemical class 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 13
- 230000002349 favourable effect Effects 0.000 description 13
- 239000012312 sodium hydride Substances 0.000 description 13
- 229910000104 sodium hydride Inorganic materials 0.000 description 13
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 12
- 108010028554 LDL Cholesterol Proteins 0.000 description 12
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 12
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 12
- LSKZHQWKSWJMIJ-OADVUDPYSA-N c1cc(C(F)(F)F)ccc1S(=O)(=O)N(C)C[C@@H]1CC[C@@H](COC\C=C\CBr)CC1 Chemical compound c1cc(C(F)(F)F)ccc1S(=O)(=O)N(C)C[C@@H]1CC[C@@H](COC\C=C\CBr)CC1 LSKZHQWKSWJMIJ-OADVUDPYSA-N 0.000 description 11
- 229910000027 potassium carbonate Inorganic materials 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- 239000003054 catalyst Substances 0.000 description 10
- 239000012280 lithium aluminium hydride Substances 0.000 description 10
- 239000012074 organic phase Substances 0.000 description 10
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 10
- 150000003138 primary alcohols Chemical class 0.000 description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- 229910052938 sodium sulfate Inorganic materials 0.000 description 10
- 235000011152 sodium sulphate Nutrition 0.000 description 10
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- RYWGPCLTVXMMHO-UHFFFAOYSA-N (4-chlorophenyl) carbonochloridate Chemical compound ClC(=O)OC1=CC=C(Cl)C=C1 RYWGPCLTVXMMHO-UHFFFAOYSA-N 0.000 description 9
- 241001024304 Mino Species 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000012230 colorless oil Substances 0.000 description 9
- 150000003512 tertiary amines Chemical class 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- YBTCGETUOCWKPC-QAQDUYKDSA-N CN(C[C@H]1CC[C@H](COCCCCBr)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](COCCCCBr)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F YBTCGETUOCWKPC-QAQDUYKDSA-N 0.000 description 8
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 8
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 239000007903 gelatin capsule Substances 0.000 description 8
- 150000004702 methyl esters Chemical class 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000000460 chlorine Substances 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 229940058690 lanosterol Drugs 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- MBEAFDHCONXXJS-UHFFFAOYSA-N sulfurochloridic acid;trifluoromethylbenzene Chemical compound OS(Cl)(=O)=O.FC(F)(F)C1=CC=CC=C1 MBEAFDHCONXXJS-UHFFFAOYSA-N 0.000 description 7
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 6
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 6
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 6
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- BJILVGIMBLMUKL-JOCQHMNTSA-N BrCCCCOC[C@@H]1CC[C@H](CC1)CN(C(O)=O)C Chemical compound BrCCCCOC[C@@H]1CC[C@H](CC1)CN(C(O)=O)C BJILVGIMBLMUKL-JOCQHMNTSA-N 0.000 description 6
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 6
- 239000005909 Kieselgur Substances 0.000 description 6
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 6
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 6
- 239000012876 carrier material Substances 0.000 description 6
- 208000029078 coronary artery disease Diseases 0.000 description 6
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 6
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 6
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 6
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 5
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 5
- UJARIIGRDCMOQX-UHFFFAOYSA-N [4-(methylaminomethyl)cyclohexyl]methanol Chemical compound CNCC1CCC(CO)CC1 UJARIIGRDCMOQX-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 150000001540 azides Chemical class 0.000 description 5
- BUELPLANVAGZOO-QIGJXJNASA-N c1cc(C(F)(F)F)ccc1S(=O)(=O)N(C)CC[C@@H]1CC[C@@H](\C=C\CCl)CC1 Chemical compound c1cc(C(F)(F)F)ccc1S(=O)(=O)N(C)CC[C@@H]1CC[C@@H](\C=C\CCl)CC1 BUELPLANVAGZOO-QIGJXJNASA-N 0.000 description 5
- 150000001805 chlorine compounds Chemical class 0.000 description 5
- 125000004093 cyano group Chemical group *C#N 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 238000005984 hydrogenation reaction Methods 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 4
- GQGACNXRFKOJRT-QAQDUYKDSA-N C1C[C@@H](C(=O)O)CC[C@@H]1OCCCCOCC1=CC=CC=C1 Chemical compound C1C[C@@H](C(=O)O)CC[C@@H]1OCCCCOCC1=CC=CC=C1 GQGACNXRFKOJRT-QAQDUYKDSA-N 0.000 description 4
- KYSXNFSWFPPJTK-KYZUINATSA-N CN(C[C@H](CC1)CC[C@@H]1C=O)C(O)=O Chemical compound CN(C[C@H](CC1)CC[C@@H]1C=O)C(O)=O KYSXNFSWFPPJTK-KYZUINATSA-N 0.000 description 4
- HGQFAYMZQBUWGS-JOCQHMNTSA-N CN(C[C@H]1CC[C@H](CO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F HGQFAYMZQBUWGS-JOCQHMNTSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 4
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 229930182558 Sterol Natural products 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- LCISOMFIAQECOH-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl] carbonochloridate Chemical compound FC(F)(F)C1=CC=C(OC(Cl)=O)C=C1 LCISOMFIAQECOH-UHFFFAOYSA-N 0.000 description 4
- 125000004450 alkenylene group Chemical group 0.000 description 4
- 125000002947 alkylene group Chemical group 0.000 description 4
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 4
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 4
- IOXXVNYDGIXMIP-UHFFFAOYSA-N n-methylprop-2-en-1-amine Chemical compound CNCC=C IOXXVNYDGIXMIP-UHFFFAOYSA-N 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 150000003432 sterols Chemical class 0.000 description 4
- 235000003702 sterols Nutrition 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 150000003509 tertiary alcohols Chemical class 0.000 description 4
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- RMXLHIUHKIVPAB-OWOJBTEDSA-N (e)-1,4-dibromobut-2-ene Chemical compound BrC\C=C\CBr RMXLHIUHKIVPAB-OWOJBTEDSA-N 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
- UWKQJZCTQGMHKD-UHFFFAOYSA-N 2,6-di-tert-butylpyridine Chemical compound CC(C)(C)C1=CC=CC(C(C)(C)C)=N1 UWKQJZCTQGMHKD-UHFFFAOYSA-N 0.000 description 3
- MIJDSYMOBYNHOT-UHFFFAOYSA-N 2-(ethylamino)ethanol Chemical compound CCNCCO MIJDSYMOBYNHOT-UHFFFAOYSA-N 0.000 description 3
- OSENKJZWYQXHBN-XVYZBDJZSA-N 24(S),25-epoxycholesterol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2CC1)C)C[C@@H]1OC1(C)C OSENKJZWYQXHBN-XVYZBDJZSA-N 0.000 description 3
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- BFFSWIMUIDMHCM-HDJSIYSDSA-N C(C)N(CCO)C[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound C(C)N(CCO)C[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C BFFSWIMUIDMHCM-HDJSIYSDSA-N 0.000 description 3
- VOFKGSSDISYLTE-IYARVYRRSA-N C1C[C@@H](C(=O)OC)CC[C@@H]1OCCCCOCC1=CC=CC=C1 Chemical compound C1C[C@@H](C(=O)OC)CC[C@@H]1OCCCCOCC1=CC=CC=C1 VOFKGSSDISYLTE-IYARVYRRSA-N 0.000 description 3
- UYBBYADRPZVQLN-CTWCUAEASA-N C1C[C@@H](COC/C=C/CNC)CC[C@@H]1CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C1C[C@@H](COC/C=C/CNC)CC[C@@H]1CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 UYBBYADRPZVQLN-CTWCUAEASA-N 0.000 description 3
- WRPYSQHJCQNNMV-KYZUINATSA-N CN(C[C@H]1CC[C@H](CO)CC1)C(O)=O Chemical compound CN(C[C@H]1CC[C@H](CO)CC1)C(O)=O WRPYSQHJCQNNMV-KYZUINATSA-N 0.000 description 3
- OIXOAKPUKLMUQS-MGCOHNPYSA-N CNC[C@H]1CC[C@H](CCO)CC1 Chemical compound CNC[C@H]1CC[C@H](CCO)CC1 OIXOAKPUKLMUQS-MGCOHNPYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- DWUPTNCOHZJANV-UHFFFAOYSA-N [4-[[tert-butyl(dimethyl)silyl]oxymethyl]cyclohexyl]methanol Chemical compound CC(C)(C)[Si](C)(C)OCC1CCC(CO)CC1 DWUPTNCOHZJANV-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 150000001350 alkyl halides Chemical class 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- 150000001414 amino alcohols Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 235000011089 carbon dioxide Nutrition 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 229940125753 fibrate Drugs 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 230000003228 microsomal effect Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- QAHVHSLSRLSVGS-UHFFFAOYSA-N sulfamoyl chloride Chemical class NS(Cl)(=O)=O QAHVHSLSRLSVGS-UHFFFAOYSA-N 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 150000008648 triflates Chemical class 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 2
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- PHGLYQGVAGLHTN-UHFFFAOYSA-N 2-(triphenyl-$l^{5}-phosphanylidene)acetic acid Chemical class C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)O)C1=CC=CC=C1 PHGLYQGVAGLHTN-UHFFFAOYSA-N 0.000 description 2
- 101710158485 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 description 2
- OZDCZHDOIBUGAJ-UHFFFAOYSA-N 4-(trifluoromethyl)benzenesulfonyl chloride Chemical compound FC(F)(F)C1=CC=C(S(Cl)(=O)=O)C=C1 OZDCZHDOIBUGAJ-UHFFFAOYSA-N 0.000 description 2
- BJDNCJGRAMGIRU-UHFFFAOYSA-M 4-bromobutyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCCBr)C1=CC=CC=C1 BJDNCJGRAMGIRU-UHFFFAOYSA-M 0.000 description 2
- ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 4-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1 ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 0.000 description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical class [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ICDDFGIENOWPQR-SHTZXODSSA-N C(C)(C)(C)OC(=O)N(C)C[C@@H]1CC[C@H](CC1)C#CCOS(=O)(=O)C Chemical compound C(C)(C)(C)OC(=O)N(C)C[C@@H]1CC[C@H](CC1)C#CCOS(=O)(=O)C ICDDFGIENOWPQR-SHTZXODSSA-N 0.000 description 2
- GZGSGPWSRSJQLJ-AZAUCVLISA-N C([C@H]1CC[C@@H](CC1)CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1)OC/C=C/CN(C)c1nc(C)ncc1 Chemical compound C([C@H]1CC[C@@H](CC1)CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1)OC/C=C/CN(C)c1nc(C)ncc1 GZGSGPWSRSJQLJ-AZAUCVLISA-N 0.000 description 2
- BJEWECMGZNGENZ-MVEJNVMZSA-N C([C@H]1CC[C@@H](CC1)COC\C=C\CN1CCCC1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C([C@H]1CC[C@@H](CC1)COC\C=C\CN1CCCC1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 BJEWECMGZNGENZ-MVEJNVMZSA-N 0.000 description 2
- PXHKXXBQFKHJCX-UYGKQXMSSA-N C([C@H]1CC[C@@H](CC1)COC\C=C\CN1CCCCC1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C([C@H]1CC[C@@H](CC1)COC\C=C\CN1CCCCC1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 PXHKXXBQFKHJCX-UYGKQXMSSA-N 0.000 description 2
- PKAOQCSLOOIDTM-JYNJEQLXSA-N C([C@H]1CC[C@@H](CC1)COC\C=C\CN1CCNCC1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C([C@H]1CC[C@@H](CC1)COC\C=C\CN1CCNCC1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 PKAOQCSLOOIDTM-JYNJEQLXSA-N 0.000 description 2
- WSASQHBZFQKNFS-JYNJEQLXSA-N C([C@H]1CC[C@@H](CC1)COC\C=C\CN1CCOCC1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C([C@H]1CC[C@@H](CC1)COC\C=C\CN1CCOCC1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 WSASQHBZFQKNFS-JYNJEQLXSA-N 0.000 description 2
- OZZIRDDLSTZQNM-MRGVAMFXSA-N C([C@H]1CC[C@@H](CC1)COC\C=C\Cn1cncc1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C([C@H]1CC[C@@H](CC1)COC\C=C\Cn1cncc1)N(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 OZZIRDDLSTZQNM-MRGVAMFXSA-N 0.000 description 2
- JGUMDOMVYXMXCH-FLCVWWEGSA-N C([C@H]1CC[C@@H](CC1)\C=C\CN1CCCCC1)CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C([C@H]1CC[C@@H](CC1)\C=C\CN1CCCCC1)CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 JGUMDOMVYXMXCH-FLCVWWEGSA-N 0.000 description 2
- RRPONLOIGZEHHT-IXFYRXCXSA-N C1C[C@@H](/C=C/CN(C)C)CC[C@@H]1CCN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C1C[C@@H](/C=C/CN(C)C)CC[C@@H]1CCN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 RRPONLOIGZEHHT-IXFYRXCXSA-N 0.000 description 2
- GYDZQVALPTVNGI-IXFYRXCXSA-N C1C[C@@H](/C=C/CNCC)CC[C@@H]1CCN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C1C[C@@H](/C=C/CNCC)CC[C@@H]1CCN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 GYDZQVALPTVNGI-IXFYRXCXSA-N 0.000 description 2
- BHOJWINTGGKOFH-IYARVYRRSA-N C1C[C@@H](C(=O)NC)CC[C@@H]1OCCCCOCC1=CC=CC=C1 Chemical compound C1C[C@@H](C(=O)NC)CC[C@@H]1OCCCCOCC1=CC=CC=C1 BHOJWINTGGKOFH-IYARVYRRSA-N 0.000 description 2
- VHQDPWARPXBEQA-MEMLXQNLSA-N CCN(CCO)CCCCOC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CCO)CCCCOC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 VHQDPWARPXBEQA-MEMLXQNLSA-N 0.000 description 2
- SYHYYPOAGOPICT-VTECNZMCSA-N CCOC(=O)\C=C\[C@H]1CC[C@H](CCN(C)C(=O)OC(C)(C)C)CC1 Chemical compound CCOC(=O)\C=C\[C@H]1CC[C@H](CCN(C)C(=O)OC(C)(C)C)CC1 SYHYYPOAGOPICT-VTECNZMCSA-N 0.000 description 2
- GCVLTDKRTZMBNB-WKILWMFISA-N CN(C(O)=O)C[C@@H]1CC[C@H](CC1)C#CCN1CCCCC1 Chemical compound CN(C(O)=O)C[C@@H]1CC[C@H](CC1)C#CCN1CCCCC1 GCVLTDKRTZMBNB-WKILWMFISA-N 0.000 description 2
- DLTAHXHVCYTEOF-QAQDUYKDSA-N CN(C(O)=O)C[C@@H]1CC[C@H](CC1)COCCCCN1CCCC1 Chemical compound CN(C(O)=O)C[C@@H]1CC[C@H](CC1)COCCCCN1CCCC1 DLTAHXHVCYTEOF-QAQDUYKDSA-N 0.000 description 2
- ADEGAWYQZLKFJW-WGSAOQKQSA-N CN(C)CCCCOC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CN(C)CCCCOC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 ADEGAWYQZLKFJW-WGSAOQKQSA-N 0.000 description 2
- GOLMIYAYMQLBHZ-MXVIHJGJSA-N CN(CCO)CCCCOC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CN(CCO)CCCCOC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 GOLMIYAYMQLBHZ-MXVIHJGJSA-N 0.000 description 2
- VCSPVQOVGSTTEK-QAQDUYKDSA-N CN(CC[C@H]1CC[C@H](Cn2ccnc2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(CC[C@H]1CC[C@H](Cn2ccnc2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F VCSPVQOVGSTTEK-QAQDUYKDSA-N 0.000 description 2
- MNSBPHLLAJMTND-HAQNSBGRSA-N CN(C[C@H]1CC[C@@H](CC1)C=O)C(=O)OC(C)(C)C Chemical compound CN(C[C@H]1CC[C@@H](CC1)C=O)C(=O)OC(C)(C)C MNSBPHLLAJMTND-HAQNSBGRSA-N 0.000 description 2
- MRVQZBNXGWAOAN-JCNLHEQBSA-N CN(C[C@H]1CC[C@@H](CC1)OCCCCO)S(=O)(=O)c1ccc(Cl)cc1 Chemical compound CN(C[C@H]1CC[C@@H](CC1)OCCCCO)S(=O)(=O)c1ccc(Cl)cc1 MRVQZBNXGWAOAN-JCNLHEQBSA-N 0.000 description 2
- AGIJAEHKHMFZAS-JCNLHEQBSA-N CN(C[C@H]1CC[C@@H](CC1)OCCCCO)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@@H](CC1)OCCCCO)S(=O)(=O)c1ccc(cc1)C(F)(F)F AGIJAEHKHMFZAS-JCNLHEQBSA-N 0.000 description 2
- MNSYBRZTYBEBTA-AQYVVDRMSA-N CN(C[C@H]1CC[C@@H](CC1)OCCCCOCc1ccccc1)C(=O)OC(C)(C)C Chemical compound CN(C[C@H]1CC[C@@H](CC1)OCCCCOCc1ccccc1)C(=O)OC(C)(C)C MNSYBRZTYBEBTA-AQYVVDRMSA-N 0.000 description 2
- PQHJGAFZYPCHBU-QAQDUYKDSA-N CN(C[C@H]1CC[C@H](CCCCCBr)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCCCCBr)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F PQHJGAFZYPCHBU-QAQDUYKDSA-N 0.000 description 2
- RQGOLZILQQJZJC-WKILWMFISA-N CN(C[C@H]1CC[C@H](CCCCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCCCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F RQGOLZILQQJZJC-WKILWMFISA-N 0.000 description 2
- MMGXEFHCIWFOLI-WKILWMFISA-N CN(C[C@H]1CC[C@H](CCO)CC1)C(=O)OCc1ccccc1 Chemical compound CN(C[C@H]1CC[C@H](CCO)CC1)C(=O)OCc1ccccc1 MMGXEFHCIWFOLI-WKILWMFISA-N 0.000 description 2
- UHGYSOAZWRBXGC-QAQDUYKDSA-N CN(C[C@H]1CC[C@H](CCn2ccnc2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCn2ccnc2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F UHGYSOAZWRBXGC-QAQDUYKDSA-N 0.000 description 2
- SYNHCDWPRRQNDD-HAQNSBGRSA-N CN(C[C@H]1CC[C@H](CO)CC1)C(=O)OC(C)(C)C Chemical compound CN(C[C@H]1CC[C@H](CO)CC1)C(=O)OC(C)(C)C SYNHCDWPRRQNDD-HAQNSBGRSA-N 0.000 description 2
- ACYOKHJTPFFQBE-MEMLXQNLSA-N CN(C[C@H]1CC[C@H](COCCCCN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](COCCCCN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F ACYOKHJTPFFQBE-MEMLXQNLSA-N 0.000 description 2
- MCKAHGQUMRQPLX-MEMLXQNLSA-N CN(C[C@H]1CC[C@H](COCCCCN2CCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](COCCCCN2CCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F MCKAHGQUMRQPLX-MEMLXQNLSA-N 0.000 description 2
- NLLXSHODISCDOR-HZCBDIJESA-N CN(C[C@H]1CC[C@H](COCCCCN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](COCCCCN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F NLLXSHODISCDOR-HZCBDIJESA-N 0.000 description 2
- XEFDABJDZBDHLW-XYPYZODXSA-N CNCC[C@H]1CC[C@H](COS(C)(=O)=O)CC1 Chemical compound CNCC[C@H]1CC[C@H](COS(C)(=O)=O)CC1 XEFDABJDZBDHLW-XYPYZODXSA-N 0.000 description 2
- NMPIKBRIWBXAOI-XYPYZODXSA-N CNC[C@H]1CC[C@@H](CC1)C#CCCl Chemical compound CNC[C@H]1CC[C@@H](CC1)C#CCCl NMPIKBRIWBXAOI-XYPYZODXSA-N 0.000 description 2
- KCNGITMJECFRMS-UAPYVXQJSA-N CNC[C@H]1CC[C@@H](CC1)OCCCCOCc1ccccc1 Chemical compound CNC[C@H]1CC[C@@H](CC1)OCCCCOCc1ccccc1 KCNGITMJECFRMS-UAPYVXQJSA-N 0.000 description 2
- HDDAKXAPNDPMGP-XYPYZODXSA-N COC(=O)[C@H]1CC[C@H](OCCCCO)CC1 Chemical compound COC(=O)[C@H]1CC[C@H](OCCCCO)CC1 HDDAKXAPNDPMGP-XYPYZODXSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- DROZJJOAYBGXMA-UBRLZZGHSA-N Cl.CNC[C@H]1CC[C@H](CCCCCBr)CC1 Chemical compound Cl.CNC[C@H]1CC[C@H](CCCCCBr)CC1 DROZJJOAYBGXMA-UBRLZZGHSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 101710095468 Cyclase Proteins 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 239000004129 EU approved improving agent Substances 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- BWRBKIXZTUUALR-SHTZXODSSA-N N1(C=NC=C1)CCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound N1(C=NC=C1)CCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C BWRBKIXZTUUALR-SHTZXODSSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- APFYTKAMSOFNBD-UHEACOROSA-N OC/C=C/[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound OC/C=C/[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C APFYTKAMSOFNBD-UHEACOROSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 2
- 238000007239 Wittig reaction Methods 0.000 description 2
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- MJSHDCCLFGOEIK-UHFFFAOYSA-N benzyl (2,5-dioxopyrrolidin-1-yl) carbonate Chemical compound O=C1CCC(=O)N1OC(=O)OCC1=CC=CC=C1 MJSHDCCLFGOEIK-UHFFFAOYSA-N 0.000 description 2
- HUZCTWYDQIQZPM-UHFFFAOYSA-N benzyl 2,2,2-trichloroethanimidate Chemical compound ClC(Cl)(Cl)C(=N)OCC1=CC=CC=C1 HUZCTWYDQIQZPM-UHFFFAOYSA-N 0.000 description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- JESCPVSKEGXYSC-UHFFFAOYSA-N chlorobenzene;sulfurochloridic acid Chemical compound OS(Cl)(=O)=O.ClC1=CC=CC=C1 JESCPVSKEGXYSC-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002440 hydroxy compounds Chemical class 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- SJFNDMHZXCUXSA-UHFFFAOYSA-M methoxymethyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(COC)C1=CC=CC=C1 SJFNDMHZXCUXSA-UHFFFAOYSA-M 0.000 description 2
- 210000001589 microsome Anatomy 0.000 description 2
- GVWISOJSERXQBM-UHFFFAOYSA-N n-methylpropan-1-amine Chemical compound CCCNC GVWISOJSERXQBM-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 2
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000006268 reductive amination reaction Methods 0.000 description 2
- 230000008844 regulatory mechanism Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- 239000008109 sodium starch glycolate Substances 0.000 description 2
- 229940079832 sodium starch glycolate Drugs 0.000 description 2
- 229920003109 sodium starch glycolate Polymers 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- MSBGPEACXKBQSX-UHFFFAOYSA-N (4-fluorophenyl) carbonochloridate Chemical compound FC1=CC=C(OC(Cl)=O)C=C1 MSBGPEACXKBQSX-UHFFFAOYSA-N 0.000 description 1
- QYIMSPSDBYKPPY-RSKUXYSASA-N (S)-2,3-epoxysqualene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CC[C@@H]1OC1(C)C QYIMSPSDBYKPPY-RSKUXYSASA-N 0.000 description 1
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- BCKHIISQSLMSEW-UHFFFAOYSA-N 4-(4-hydroxybutoxy)benzoic acid Chemical compound OCCCCOC1=CC=C(C(O)=O)C=C1 BCKHIISQSLMSEW-UHFFFAOYSA-N 0.000 description 1
- SVENICJJGFDSBB-UHFFFAOYSA-N 4-(4-phenylmethoxybutoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OCCCCOCC1=CC=CC=C1 SVENICJJGFDSBB-UHFFFAOYSA-N 0.000 description 1
- WDTVJRYCMIZPMX-UHFFFAOYSA-N 4-chloro-2-methylpyrimidine Chemical compound CC1=NC=CC(Cl)=N1 WDTVJRYCMIZPMX-UHFFFAOYSA-N 0.000 description 1
- TYROJDFHUXSBHC-UHFFFAOYSA-N 4-phenylmethoxybutan-1-ol Chemical compound OCCCCOCC1=CC=CC=C1 TYROJDFHUXSBHC-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 1
- 239000001715 Ammonium malate Substances 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- DBJHDHQCXAVEHZ-WKILWMFISA-N C(C)(C)(C)OC(=O)N(CC[C@@H]1CC[C@H](CC1)CCCOS(=O)(=O)C)C Chemical compound C(C)(C)(C)OC(=O)N(CC[C@@H]1CC[C@H](CC1)CCCOS(=O)(=O)C)C DBJHDHQCXAVEHZ-WKILWMFISA-N 0.000 description 1
- WYNBMTXXQVJHNR-JOCQHMNTSA-N C(C)(C)(C)[SiH2]OC([C@@H]1CC[C@H](CC1)CC#N)(C)C Chemical compound C(C)(C)(C)[SiH2]OC([C@@H]1CC[C@H](CC1)CC#N)(C)C WYNBMTXXQVJHNR-JOCQHMNTSA-N 0.000 description 1
- GTVNPQUSDXAZLO-JOCQHMNTSA-N C(C)(C)(C)[SiH2]OC([C@@H]1CC[C@H](CC1)COS(=O)(=O)C)(C)C Chemical compound C(C)(C)(C)[SiH2]OC([C@@H]1CC[C@H](CC1)COS(=O)(=O)C)(C)C GTVNPQUSDXAZLO-JOCQHMNTSA-N 0.000 description 1
- BPKMYCPOENHIPG-QAQDUYKDSA-N C(C)N(CCCCOC[C@@H]1CC[C@H](CC1)CN(C(O)=O)C)CCO Chemical compound C(C)N(CCCCOC[C@@H]1CC[C@H](CC1)CN(C(O)=O)C)CCO BPKMYCPOENHIPG-QAQDUYKDSA-N 0.000 description 1
- ZCVRBCARCCZYEK-WKILWMFISA-N C(C)N(CCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C)CCO Chemical compound C(C)N(CCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C)CCO ZCVRBCARCCZYEK-WKILWMFISA-N 0.000 description 1
- IZHZEXZPJGUFAM-DQPSWOJKSA-N C(C)NC/C=C/[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound C(C)NC/C=C/[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C IZHZEXZPJGUFAM-DQPSWOJKSA-N 0.000 description 1
- SNHWGZGDLNQWDC-JOCQHMNTSA-N C(C)NCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound C(C)NCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C SNHWGZGDLNQWDC-JOCQHMNTSA-N 0.000 description 1
- RRSPHEPRJHEXPY-FLCVWWEGSA-N C([C@H]1CC[C@@H](CC1)\C=C\CN1CCCCC1)CN(C)C(=O)Oc1ccc(Cl)cc1 Chemical compound C([C@H]1CC[C@@H](CC1)\C=C\CN1CCCCC1)CN(C)C(=O)Oc1ccc(Cl)cc1 RRSPHEPRJHEXPY-FLCVWWEGSA-N 0.000 description 1
- IZASRGWUQFSYCN-IXFYRXCXSA-N C1C[C@@H](/C=C/CN(C)C)CC[C@@H]1CCN(C)C(=O)Oc1ccc(Cl)cc1 Chemical compound C1C[C@@H](/C=C/CN(C)C)CC[C@@H]1CCN(C)C(=O)Oc1ccc(Cl)cc1 IZASRGWUQFSYCN-IXFYRXCXSA-N 0.000 description 1
- BRWDSSFWNLIIPV-IXFYRXCXSA-N C1C[C@@H](/C=C/CNCC)CC[C@@H]1CCN(C)C(=O)Oc1ccc(Cl)cc1 Chemical compound C1C[C@@H](/C=C/CNCC)CC[C@@H]1CCN(C)C(=O)Oc1ccc(Cl)cc1 BRWDSSFWNLIIPV-IXFYRXCXSA-N 0.000 description 1
- LEKVVTNGIDTQLF-AHAWPRANSA-N C1C[C@@H](COC/C=C/CN(CCO)C)CC[C@@H]1CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C1C[C@@H](COC/C=C/CN(CCO)C)CC[C@@H]1CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 LEKVVTNGIDTQLF-AHAWPRANSA-N 0.000 description 1
- IWMSQZNQOBVCOH-MVEJNVMZSA-N C1C[C@@H](COC/C=C/CN(CCO)CC)CC[C@@H]1CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 Chemical compound C1C[C@@H](COC/C=C/CN(CCO)CC)CC[C@@H]1CN(C)S(=O)(=O)c1ccc(C(F)(F)F)cc1 IWMSQZNQOBVCOH-MVEJNVMZSA-N 0.000 description 1
- NZABBTAWTVOQHP-HSDLRMROSA-N CC(C)(C)OC(=O)N(C)CC[C@H]1CC[C@H](\C=C\CO)CC1 Chemical compound CC(C)(C)OC(=O)N(C)CC[C@H]1CC[C@H](\C=C\CO)CC1 NZABBTAWTVOQHP-HSDLRMROSA-N 0.000 description 1
- YFXLRJZHNLPAJM-HAQNSBGRSA-N CC(C)(C)OC(=O)NCC[C@H]1CC[C@H](CO)CC1 Chemical compound CC(C)(C)OC(=O)NCC[C@H]1CC[C@H](CO)CC1 YFXLRJZHNLPAJM-HAQNSBGRSA-N 0.000 description 1
- NJELIHYYBUXRNI-FOUKWCRFSA-N CC(O)CN(CC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1)CC(C)O Chemical compound CC(O)CN(CC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1)CC(C)O NJELIHYYBUXRNI-FOUKWCRFSA-N 0.000 description 1
- SHWRXHCOOPRJRX-MXVIHJGJSA-N CCN(CC)CCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CC)CCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 SHWRXHCOOPRJRX-MXVIHJGJSA-N 0.000 description 1
- SPCHZDNKAIUFFZ-QAQDUYKDSA-N CCN(CC)C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CC)C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 SPCHZDNKAIUFFZ-QAQDUYKDSA-N 0.000 description 1
- POTQRHZDSXDDFI-WGSAOQKQSA-N CCN(CCO)CC#C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CCO)CC#C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 POTQRHZDSXDDFI-WGSAOQKQSA-N 0.000 description 1
- LESRKBXIWHLTGY-MEMLXQNLSA-N CCN(CCO)CCCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CCO)CCCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 LESRKBXIWHLTGY-MEMLXQNLSA-N 0.000 description 1
- YYDKZWQJVFPSGQ-XUTJKUGGSA-N CCN(CCO)CCCCO[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CCO)CCCCO[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 YYDKZWQJVFPSGQ-XUTJKUGGSA-N 0.000 description 1
- CGKLUVVRBRTRHU-MXVIHJGJSA-N CCN(CCO)CCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CCO)CCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 CGKLUVVRBRTRHU-MXVIHJGJSA-N 0.000 description 1
- NCUBUGLMSXDAFE-WGSAOQKQSA-N CCN(CCO)CC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 Chemical compound CCN(CCO)CC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 NCUBUGLMSXDAFE-WGSAOQKQSA-N 0.000 description 1
- UJJYRRIZDHUGIQ-IYARVYRRSA-N CCN(CCO)CC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CCO)CC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 UJJYRRIZDHUGIQ-IYARVYRRSA-N 0.000 description 1
- BCUWQWVZRUSBSR-IYARVYRRSA-N CCN(CCO)C[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 Chemical compound CCN(CCO)C[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 BCUWQWVZRUSBSR-IYARVYRRSA-N 0.000 description 1
- VRBXGXHNUJIBTK-IYARVYRRSA-N CCN(CCO)C[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CCO)C[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 VRBXGXHNUJIBTK-IYARVYRRSA-N 0.000 description 1
- KNARPFDXFYBKQR-QAQDUYKDSA-N CCN(CCO)C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCN(CCO)C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 KNARPFDXFYBKQR-QAQDUYKDSA-N 0.000 description 1
- QIJIQYLRRLAJHJ-QAQDUYKDSA-N CCNCC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 Chemical compound CCNCC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 QIJIQYLRRLAJHJ-QAQDUYKDSA-N 0.000 description 1
- IEKNDOVCXLUKME-WKILWMFISA-N CCNC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 Chemical compound CCNC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 IEKNDOVCXLUKME-WKILWMFISA-N 0.000 description 1
- TYLJIQHBTKKXPE-SHTZXODSSA-N CCNC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CCNC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 TYLJIQHBTKKXPE-SHTZXODSSA-N 0.000 description 1
- LMFXXQGDPNMGGP-XYPYZODXSA-N CN(C(O)=O)CC[C@@H]1CC[C@H](CC1)CC=O Chemical compound CN(C(O)=O)CC[C@@H]1CC[C@H](CC1)CC=O LMFXXQGDPNMGGP-XYPYZODXSA-N 0.000 description 1
- VMMCQJWJWILSIM-IYARVYRRSA-N CN(C(O)=O)C[C@@H]1CC[C@H](CC1)COCCCCN1CCCCC1 Chemical compound CN(C(O)=O)C[C@@H]1CC[C@H](CC1)COCCCCN1CCCCC1 VMMCQJWJWILSIM-IYARVYRRSA-N 0.000 description 1
- GOZRMTGZTNEKLJ-WGSAOQKQSA-N CN(C)CCCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CN(C)CCCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 GOZRMTGZTNEKLJ-WGSAOQKQSA-N 0.000 description 1
- CGGAKLXJXUHLTH-WGSAOQKQSA-N CN(C)CCCCOC[C@H]1CC[C@H](CN(C)C(=O)Oc2ccc(Cl)cc2)CC1 Chemical compound CN(C)CCCCOC[C@H]1CC[C@H](CN(C)C(=O)Oc2ccc(Cl)cc2)CC1 CGGAKLXJXUHLTH-WGSAOQKQSA-N 0.000 description 1
- SUAOEYHAJVVULX-IYARVYRRSA-N CN(C)CCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CN(C)CCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 SUAOEYHAJVVULX-IYARVYRRSA-N 0.000 description 1
- CAMSWPIXDSPQCJ-QAQDUYKDSA-N CN(C)CC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 Chemical compound CN(C)CC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 CAMSWPIXDSPQCJ-QAQDUYKDSA-N 0.000 description 1
- PSNFJAVDBMBVPZ-WKILWMFISA-N CN(C)C[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 Chemical compound CN(C)C[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 PSNFJAVDBMBVPZ-WKILWMFISA-N 0.000 description 1
- LPQCITGAFXCIQF-WKILWMFISA-N CN(C)C[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CN(C)C[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 LPQCITGAFXCIQF-WKILWMFISA-N 0.000 description 1
- HJSDFVJCYLZHER-SHTZXODSSA-N CN(C)C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CN(C)C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 HJSDFVJCYLZHER-SHTZXODSSA-N 0.000 description 1
- OKISMAFYOVUVKQ-SHTZXODSSA-N CN(CCCCOC[C@@H]1CC[C@H](CC1)CN(C(O)=O)C)C Chemical compound CN(CCCCOC[C@@H]1CC[C@H](CC1)CN(C(O)=O)C)C OKISMAFYOVUVKQ-SHTZXODSSA-N 0.000 description 1
- OVEUIHGAURJMFS-MXVIHJGJSA-N CN(CCO)CCCCOC[C@H]1CC[C@H](CN(C)C(=O)Oc2ccc(Cl)cc2)CC1 Chemical compound CN(CCO)CCCCOC[C@H]1CC[C@H](CN(C)C(=O)Oc2ccc(Cl)cc2)CC1 OVEUIHGAURJMFS-MXVIHJGJSA-N 0.000 description 1
- FBMHGYQERAVRHF-JOCQHMNTSA-N CN(CC[C@H]1CC[C@@H](CC1)C=O)C(=O)OC(C)(C)C Chemical compound CN(CC[C@H]1CC[C@@H](CC1)C=O)C(=O)OC(C)(C)C FBMHGYQERAVRHF-JOCQHMNTSA-N 0.000 description 1
- ILWKQKAZOIYEPQ-HDJSIYSDSA-N CN(CC[C@H]1CC[C@H](CC#N)CC1)C(=O)OC(C)(C)C Chemical compound CN(CC[C@H]1CC[C@H](CC#N)CC1)C(=O)OC(C)(C)C ILWKQKAZOIYEPQ-HDJSIYSDSA-N 0.000 description 1
- WWTCQWYRERRGKM-SHTZXODSSA-N CN(CC[C@H]1CC[C@H](CCCO)CC1)C(=O)OC(C)(C)C Chemical compound CN(CC[C@H]1CC[C@H](CCCO)CC1)C(=O)OC(C)(C)C WWTCQWYRERRGKM-SHTZXODSSA-N 0.000 description 1
- AKNIFXUUDMTKDA-MXVIHJGJSA-N CN(CC[C@H]1CC[C@H](CCN2CCCCC2)CC1)S(=O)(=O)c1ccc(Cl)cc1 Chemical compound CN(CC[C@H]1CC[C@H](CCN2CCCCC2)CC1)S(=O)(=O)c1ccc(Cl)cc1 AKNIFXUUDMTKDA-MXVIHJGJSA-N 0.000 description 1
- XHALMYCHTGYCEA-IYARVYRRSA-N CN(CC[C@H]1CC[C@H](CN2CCCC2)CC1)S(=O)(=O)c1ccc(Cl)cc1 Chemical compound CN(CC[C@H]1CC[C@H](CN2CCCC2)CC1)S(=O)(=O)c1ccc(Cl)cc1 XHALMYCHTGYCEA-IYARVYRRSA-N 0.000 description 1
- SLXFXGZILXIKQU-WGSAOQKQSA-N CN(CC[C@H]1CC[C@H](CN2CCCCC2)CC1)S(=O)(=O)c1ccc(Cl)cc1 Chemical compound CN(CC[C@H]1CC[C@H](CN2CCCCC2)CC1)S(=O)(=O)c1ccc(Cl)cc1 SLXFXGZILXIKQU-WGSAOQKQSA-N 0.000 description 1
- QJGBBCSPVSTYNC-WGSAOQKQSA-N CN(CC[C@H]1CC[C@H](CN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(CC[C@H]1CC[C@H](CN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F QJGBBCSPVSTYNC-WGSAOQKQSA-N 0.000 description 1
- NOTZLWCOLFTLGY-WGSAOQKQSA-N CN(CC[C@H]1CC[C@H](CN2CCN(C)CC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(CC[C@H]1CC[C@H](CN2CCN(C)CC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F NOTZLWCOLFTLGY-WGSAOQKQSA-N 0.000 description 1
- CGGMDDVCIQVHIA-QAQDUYKDSA-N CN(CC[C@H]1CC[C@H](CNC(C)(C)CO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(CC[C@H]1CC[C@H](CNC(C)(C)CO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F CGGMDDVCIQVHIA-QAQDUYKDSA-N 0.000 description 1
- ZCFYZKSNVINJJW-MXVIHJGJSA-N CN(CC[C@H]1CC[C@H](CNCCCCCCO)CC1)S(=O)(=O)c1ccc(Cl)cc1 Chemical compound CN(CC[C@H]1CC[C@H](CNCCCCCCO)CC1)S(=O)(=O)c1ccc(Cl)cc1 ZCFYZKSNVINJJW-MXVIHJGJSA-N 0.000 description 1
- QOTMUAWOELVOBC-WGSAOQKQSA-N CN(CC[C@H]1CC[C@H](CNCCCCCO)CC1)S(=O)(=O)c1ccc(Cl)cc1 Chemical compound CN(CC[C@H]1CC[C@H](CNCCCCCO)CC1)S(=O)(=O)c1ccc(Cl)cc1 QOTMUAWOELVOBC-WGSAOQKQSA-N 0.000 description 1
- RXCLMWNMTDRMSX-WKILWMFISA-N CN(CC[C@H]1CC[C@H](CNCCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(CC[C@H]1CC[C@H](CNCCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F RXCLMWNMTDRMSX-WKILWMFISA-N 0.000 description 1
- OUZUUSAACWKCLP-MGCOHNPYSA-N CN(CC[C@H]1CC[C@H](CO)CC1)C(O)=O Chemical compound CN(CC[C@H]1CC[C@H](CO)CC1)C(O)=O OUZUUSAACWKCLP-MGCOHNPYSA-N 0.000 description 1
- QSIUIOFKQXQZGN-MXVIHJGJSA-N CN(C[C@H]1CC[C@@H](CC1)C#CCN1CCCCC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@@H](CC1)C#CCN1CCCCC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F QSIUIOFKQXQZGN-MXVIHJGJSA-N 0.000 description 1
- XSMKEVRGSWCQPO-WKILWMFISA-N CN(C[C@H]1CC[C@@H](CC1)C#CCOS(C)(=O)=O)C(=O)Oc1ccc(Cl)cc1 Chemical compound CN(C[C@H]1CC[C@@H](CC1)C#CCOS(C)(=O)=O)C(=O)Oc1ccc(Cl)cc1 XSMKEVRGSWCQPO-WKILWMFISA-N 0.000 description 1
- MYTULRWEWBTLJL-SHTZXODSSA-N CN(C[C@H]1CC[C@@H](CC1)C=O)C(=O)OCc1ccccc1 Chemical compound CN(C[C@H]1CC[C@@H](CC1)C=O)C(=O)OCc1ccccc1 MYTULRWEWBTLJL-SHTZXODSSA-N 0.000 description 1
- NQXQIRVRVVQKIU-SHTZXODSSA-N CN(C[C@H]1CC[C@@H](CC1)OCCCCO)C(=O)OC(C)(C)C Chemical compound CN(C[C@H]1CC[C@@H](CC1)OCCCCO)C(=O)OC(C)(C)C NQXQIRVRVVQKIU-SHTZXODSSA-N 0.000 description 1
- AXMPBXXWCRLVJP-JCNLHEQBSA-N CN(C[C@H]1CC[C@@H](CC1)OCCCCO)C(=O)Oc1ccc(Cl)cc1 Chemical compound CN(C[C@H]1CC[C@@H](CC1)OCCCCO)C(=O)Oc1ccc(Cl)cc1 AXMPBXXWCRLVJP-JCNLHEQBSA-N 0.000 description 1
- AAHXLZJDEDJFCU-WKILWMFISA-N CN(C[C@H]1CC[C@H](CC=O)CC1)C(=O)OCc1ccccc1 Chemical compound CN(C[C@H]1CC[C@H](CC=O)CC1)C(=O)OCc1ccccc1 AAHXLZJDEDJFCU-WKILWMFISA-N 0.000 description 1
- WMYNXXVCNXIXIN-WKILWMFISA-N CN(C[C@H]1CC[C@H](CCCCCBr)CC1)C(=O)OC(C)(C)C Chemical compound CN(C[C@H]1CC[C@H](CCCCCBr)CC1)C(=O)OC(C)(C)C WMYNXXVCNXIXIN-WKILWMFISA-N 0.000 description 1
- QMCFJIZSCXTOLH-JOCQHMNTSA-N CN(C[C@H]1CC[C@H](CCCCCBr)CC1)C(O)=O Chemical compound CN(C[C@H]1CC[C@H](CCCCCBr)CC1)C(O)=O QMCFJIZSCXTOLH-JOCQHMNTSA-N 0.000 description 1
- JPBCMOSAGUBIRS-MEMLXQNLSA-N CN(C[C@H]1CC[C@H](CCCCCN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCCCCN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F JPBCMOSAGUBIRS-MEMLXQNLSA-N 0.000 description 1
- ILMIKNZMKFVEBV-MEMLXQNLSA-N CN(C[C@H]1CC[C@H](CCCCCN2CCC(O)CC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCCCCN2CCC(O)CC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F ILMIKNZMKFVEBV-MEMLXQNLSA-N 0.000 description 1
- YGMSYPYKZYARCM-MEMLXQNLSA-N CN(C[C@H]1CC[C@H](CCCCCN2CCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCCCCN2CCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F YGMSYPYKZYARCM-MEMLXQNLSA-N 0.000 description 1
- CUGXUEUQWKNZMK-HZCBDIJESA-N CN(C[C@H]1CC[C@H](CCCCCN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCCCCN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F CUGXUEUQWKNZMK-HZCBDIJESA-N 0.000 description 1
- FBGWFIOZIYAOCR-MXVIHJGJSA-N CN(C[C@H]1CC[C@H](CCCCN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCCCN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F FBGWFIOZIYAOCR-MXVIHJGJSA-N 0.000 description 1
- NJKQPBRYMRASBE-WKILWMFISA-N CN(C[C@H]1CC[C@H](CCCCO)CC1)C(=O)Oc1ccc(Cl)cc1 Chemical compound CN(C[C@H]1CC[C@H](CCCCO)CC1)C(=O)Oc1ccc(Cl)cc1 NJKQPBRYMRASBE-WKILWMFISA-N 0.000 description 1
- YHCBFBVQCMONCU-HDJSIYSDSA-N CN(C[C@H]1CC[C@H](CCCO)CC1)C(=O)OC(C)(C)C Chemical compound CN(C[C@H]1CC[C@H](CCCO)CC1)C(=O)OC(C)(C)C YHCBFBVQCMONCU-HDJSIYSDSA-N 0.000 description 1
- IDNRUOFDOUWNKE-SHTZXODSSA-N CN(C[C@H]1CC[C@H](CCCO)CC1)C(=O)Oc1ccc(Cl)cc1 Chemical compound CN(C[C@H]1CC[C@H](CCCO)CC1)C(=O)Oc1ccc(Cl)cc1 IDNRUOFDOUWNKE-SHTZXODSSA-N 0.000 description 1
- KUACPLLFARTAQS-SHTZXODSSA-N CN(C[C@H]1CC[C@H](CCCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F KUACPLLFARTAQS-SHTZXODSSA-N 0.000 description 1
- GKLWVHBINDHDGO-HDJSIYSDSA-N CN(C[C@H]1CC[C@H](CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F GKLWVHBINDHDGO-HDJSIYSDSA-N 0.000 description 1
- FQZLORDYGCUEFC-QAQDUYKDSA-N CN(C[C@H]1CC[C@H](CN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CN(CCO)CCO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F FQZLORDYGCUEFC-QAQDUYKDSA-N 0.000 description 1
- OQMNXAHTIPKFIW-WKILWMFISA-N CN(C[C@H]1CC[C@H](CN2CCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CN2CCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F OQMNXAHTIPKFIW-WKILWMFISA-N 0.000 description 1
- XXAXKKZWXGAYBA-QAQDUYKDSA-N CN(C[C@H]1CC[C@H](CN2CCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CN2CCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F XXAXKKZWXGAYBA-QAQDUYKDSA-N 0.000 description 1
- UAJHDARXVPMPKM-IYARVYRRSA-N CN(C[C@H]1CC[C@H](CN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](CN2CCCCC2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F UAJHDARXVPMPKM-IYARVYRRSA-N 0.000 description 1
- LFXAZPFDTYLIGO-SHTZXODSSA-N CN(C[C@H]1CC[C@H](CO)CC1)C(=O)OCc1ccccc1 Chemical compound CN(C[C@H]1CC[C@H](CO)CC1)C(=O)OCc1ccccc1 LFXAZPFDTYLIGO-SHTZXODSSA-N 0.000 description 1
- YDPNYOACYRUFMV-JOCQHMNTSA-N CN(C[C@H]1CC[C@H](CO)CC1)C(=O)Oc1ccc(Cl)cc1 Chemical compound CN(C[C@H]1CC[C@H](CO)CC1)C(=O)Oc1ccc(Cl)cc1 YDPNYOACYRUFMV-JOCQHMNTSA-N 0.000 description 1
- HDIOOKWLVPBEFS-MEMLXQNLSA-N CN(C[C@H]1CC[C@H](COCCCCN(CCO)CCO)CC1)C(=O)Oc1ccc(Cl)cc1 Chemical compound CN(C[C@H]1CC[C@H](COCCCCN(CCO)CCO)CC1)C(=O)Oc1ccc(Cl)cc1 HDIOOKWLVPBEFS-MEMLXQNLSA-N 0.000 description 1
- GFUQJQRDHFOYCR-HZCBDIJESA-N CN(C[C@H]1CC[C@H](COCCCCN2CCCCC2)CC1)C(=O)Oc1ccc(Cl)cc1 Chemical compound CN(C[C@H]1CC[C@H](COCCCCN2CCCCC2)CC1)C(=O)Oc1ccc(Cl)cc1 GFUQJQRDHFOYCR-HZCBDIJESA-N 0.000 description 1
- GVFBRMFGZTXRTR-FUDKSRODSA-N CN(C[C@H]1CC[C@H](COCCCCN2CCC[C@H]2CO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](COCCCCN2CCC[C@H]2CO)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F GVFBRMFGZTXRTR-FUDKSRODSA-N 0.000 description 1
- SKWWPOJUKWIBJE-WKILWMFISA-N CN(C[C@H]1CC[C@H](Cn2ccnc2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F Chemical compound CN(C[C@H]1CC[C@H](Cn2ccnc2)CC1)S(=O)(=O)c1ccc(cc1)C(F)(F)F SKWWPOJUKWIBJE-WKILWMFISA-N 0.000 description 1
- BNPASMHASNNUMO-SHTZXODSSA-N CN(S(=O)(=O)C1=CC=C(C=C1)C(F)(F)F)C[C@@H]1CC[C@H](CC1)CCOS(=O)(=O)C Chemical compound CN(S(=O)(=O)C1=CC=C(C=C1)C(F)(F)F)C[C@@H]1CC[C@H](CC1)CCOS(=O)(=O)C BNPASMHASNNUMO-SHTZXODSSA-N 0.000 description 1
- ZEDDKCURPDPOBX-WKILWMFISA-N CNCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CNCCC[C@H]1CC[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 ZEDDKCURPDPOBX-WKILWMFISA-N 0.000 description 1
- DUUGTQNMXWHOLG-WKILWMFISA-N CNCC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 Chemical compound CNCC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(Cl)cc2)CC1 DUUGTQNMXWHOLG-WKILWMFISA-N 0.000 description 1
- DARXFVTUKPQUIH-UHEACOROSA-N CNCC[C@H]1CC[C@H](\C=C\CO)CC1 Chemical compound CNCC[C@H]1CC[C@H](\C=C\CO)CC1 DARXFVTUKPQUIH-UHEACOROSA-N 0.000 description 1
- SZGSSYJXADEBOE-SHTZXODSSA-N CNC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 Chemical compound CNC[C@H]1CC[C@H](CCN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)CC1 SZGSSYJXADEBOE-SHTZXODSSA-N 0.000 description 1
- WZVKFWVYXDVORF-HDJSIYSDSA-N COC(CC[C@@H]1CC[C@H](CC1)CN(C)C(=O)OC(C)(C)C)=O Chemical compound COC(CC[C@@H]1CC[C@H](CC1)CN(C)C(=O)OC(C)(C)C)=O WZVKFWVYXDVORF-HDJSIYSDSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000004410 Cholesterol 7-alpha-monooxygenases Human genes 0.000 description 1
- 108090000943 Cholesterol 7-alpha-monooxygenases Proteins 0.000 description 1
- MAISEICFZZUPBI-QAQDUYKDSA-N ClC1=CC=C(OC(=O)N(CC[C@@H]2CC[C@H](CC2)CCCOS(=O)(=O)C)C)C=C1 Chemical compound ClC1=CC=C(OC(=O)N(CC[C@@H]2CC[C@H](CC2)CCCOS(=O)(=O)C)C)C=C1 MAISEICFZZUPBI-QAQDUYKDSA-N 0.000 description 1
- UGSGEEJIAGHQHX-XYPYZODXSA-N ClCC#C[C@@H]1CC[C@H](CC1)CN(C(O)=O)C Chemical compound ClCC#C[C@@H]1CC[C@H](CC1)CN(C(O)=O)C UGSGEEJIAGHQHX-XYPYZODXSA-N 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010033266 Lipoprotein(a) Proteins 0.000 description 1
- 102000057248 Lipoprotein(a) Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- NJPJBRYEOAWSNQ-QAQDUYKDSA-N OC1CCN(CC1)CCCCC[C@@H]1CC[C@H](CC1)CN(C(O)=O)C Chemical compound OC1CCN(CC1)CCCCC[C@@H]1CC[C@H](CC1)CN(C(O)=O)C NJPJBRYEOAWSNQ-QAQDUYKDSA-N 0.000 description 1
- NMDFBOSXOFKPSI-QAQDUYKDSA-N OCCCCCCNCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound OCCCCCCNCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C NMDFBOSXOFKPSI-QAQDUYKDSA-N 0.000 description 1
- CMRVHWXKNSQROR-WKILWMFISA-N OCCCCCCNC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound OCCCCCCNC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C CMRVHWXKNSQROR-WKILWMFISA-N 0.000 description 1
- FBIIUZUGIYOBEF-WKILWMFISA-N OCCCCCNCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound OCCCCCNCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C FBIIUZUGIYOBEF-WKILWMFISA-N 0.000 description 1
- VYYRFTGUBXBASZ-SHTZXODSSA-N OCCCCCNC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound OCCCCCNC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C VYYRFTGUBXBASZ-SHTZXODSSA-N 0.000 description 1
- LYRHYVAPEVEELX-XYPYZODXSA-N OCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C Chemical compound OCC[C@@H]1CC[C@H](CC1)CCN(C(O)=O)C LYRHYVAPEVEELX-XYPYZODXSA-N 0.000 description 1
- XTGZKVUBHYJWEG-KYZUINATSA-N OC[C@@H]1CC[C@H](CC1)CCNC(O)=O Chemical compound OC[C@@H]1CC[C@H](CC1)CCNC(O)=O XTGZKVUBHYJWEG-KYZUINATSA-N 0.000 description 1
- PRLNJRWXSJVNIE-ZKCHVHJHSA-N OC[C@H]1CC[C@H](CNC(O)=O)CC1 Chemical compound OC[C@H]1CC[C@H](CNC(O)=O)CC1 PRLNJRWXSJVNIE-ZKCHVHJHSA-N 0.000 description 1
- QYIMSPSDBYKPPY-UHFFFAOYSA-N OS Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC1OC1(C)C QYIMSPSDBYKPPY-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 229930184636 Talaromycin Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HVVNJUAVDAZWCB-YFKPBYRVSA-N [(2s)-pyrrolidin-2-yl]methanol Chemical compound OC[C@@H]1CCCN1 HVVNJUAVDAZWCB-YFKPBYRVSA-N 0.000 description 1
- ORLQHILJRHBSAY-UHFFFAOYSA-N [1-(hydroxymethyl)cyclohexyl]methanol Chemical class OCC1(CO)CCCCC1 ORLQHILJRHBSAY-UHFFFAOYSA-N 0.000 description 1
- QGUMPFXESXXCTG-UHFFFAOYSA-N [4-(2-tert-butylsilyloxypropan-2-yl)cyclohexyl]methanol Chemical class C(C)(C)(C)[SiH2]OC(C1CCC(CC1)CO)(C)C QGUMPFXESXXCTG-UHFFFAOYSA-N 0.000 description 1
- YIMQCDZDWXUDCA-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1CCC(CO)CC1 YIMQCDZDWXUDCA-UHFFFAOYSA-N 0.000 description 1
- NBBIPGXZNSROLU-UHFFFAOYSA-N [4-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]cyclohexyl]methyl acetate Chemical compound CC(=O)OCC1CCC(CCNC(=O)OC(C)(C)C)CC1 NBBIPGXZNSROLU-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000019292 ammonium malate Nutrition 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 230000036523 atherogenesis Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960005370 atorvastatin Drugs 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 125000006515 benzyloxy alkyl group Chemical group 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 229920000080 bile acid sequestrant Polymers 0.000 description 1
- 229940096699 bile acid sequestrants Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- MXOSTENCGSDMRE-UHFFFAOYSA-N butyl-chloro-dimethylsilane Chemical compound CCCC[Si](C)(C)Cl MXOSTENCGSDMRE-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- DNFWHXVYOBSJFF-JYNJEQLXSA-N c1cc(C(F)(F)F)ccc1S(=O)(=O)N(C)C[C@@H]1CC[C@@H](COC\C=C\CN(CCO)CCO)CC1 Chemical compound c1cc(C(F)(F)F)ccc1S(=O)(=O)N(C)C[C@@H]1CC[C@@H](COC\C=C\CN(CCO)CCO)CC1 DNFWHXVYOBSJFF-JYNJEQLXSA-N 0.000 description 1
- MKCVIVGIBQTBNE-QIGJXJNASA-N c1cc(Cl)ccc1OC(=O)N(C)CC[C@@H]1CC[C@@H](\C=C\CO)CC1 Chemical compound c1cc(Cl)ccc1OC(=O)N(C)CC[C@@H]1CC[C@@H](\C=C\CO)CC1 MKCVIVGIBQTBNE-QIGJXJNASA-N 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- MUXRZYNIEMIEAL-IYARVYRRSA-N chembl2219824 Chemical compound C1C[C@@H](CN(CCO)CC)CC[C@@H]1CCN(C)C(=O)OC1=CC=C(C(F)(F)F)C=C1 MUXRZYNIEMIEAL-IYARVYRRSA-N 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 230000001587 cholestatic effect Effects 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000009850 completed effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 150000001934 cyclohexanes Chemical class 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- LCSNDSFWVKMJCT-UHFFFAOYSA-N dicyclohexyl-(2-phenylphenyl)phosphane Chemical group C1CCCCC1P(C=1C(=CC=CC=1)C=1C=CC=CC=1)C1CCCCC1 LCSNDSFWVKMJCT-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- RPNNPZHFJPXFQS-UHFFFAOYSA-N methane;rhodium Chemical compound C.[Rh] RPNNPZHFJPXFQS-UHFFFAOYSA-N 0.000 description 1
- LLCOIQRNSJBFSN-UHFFFAOYSA-N methane;sulfurochloridic acid Chemical compound C.OS(Cl)(=O)=O LLCOIQRNSJBFSN-UHFFFAOYSA-N 0.000 description 1
- 229940087646 methanolamine Drugs 0.000 description 1
- NTNUDYROPUKXNA-UHFFFAOYSA-N methyl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OC)C1=CC=CC=C1 NTNUDYROPUKXNA-UHFFFAOYSA-N 0.000 description 1
- PDCLMKLXKCEAPR-UHFFFAOYSA-N methyl 4-(4-hydroxybutoxy)benzoate Chemical compound COC(=O)C1=CC=C(OCCCCO)C=C1 PDCLMKLXKCEAPR-UHFFFAOYSA-N 0.000 description 1
- QDUFWILLJZWQBE-UHFFFAOYSA-N methyl 4-(4-phenylmethoxybutoxy)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1OCCCCOCC1=CC=CC=C1 QDUFWILLJZWQBE-UHFFFAOYSA-N 0.000 description 1
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Chemical class 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical class [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- CASUWPDYGGAUQV-UHFFFAOYSA-M potassium;methanol;hydroxide Chemical compound [OH-].[K+].OC CASUWPDYGGAUQV-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011324 primary prophylaxis Methods 0.000 description 1
- FYPMFJGVHOHGLL-UHFFFAOYSA-N probucol Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1SC(C)(C)SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FYPMFJGVHOHGLL-UHFFFAOYSA-N 0.000 description 1
- 229960003912 probucol Drugs 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000018770 reduced food intake Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004141 reverse cholesterol transport Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000011301 standard therapy Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical class NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- MFPWEWYKQYMWRO-UHFFFAOYSA-N tert-butyl carboxy carbonate Chemical compound CC(C)(C)OC(=O)OC(O)=O MFPWEWYKQYMWRO-UHFFFAOYSA-N 0.000 description 1
- ODZXPJPKMVQLAU-UHFFFAOYSA-N tert-butyl n-[2-[4-(hydroxymethyl)cyclohexyl]ethyl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)CCC1CCC(CO)CC1 ODZXPJPKMVQLAU-UHFFFAOYSA-N 0.000 description 1
- KSXPGASLEFGROT-UHFFFAOYSA-N tert-butyl n-[[4-(hydroxymethyl)cyclohexyl]methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1CCC(CO)CC1 KSXPGASLEFGROT-UHFFFAOYSA-N 0.000 description 1
- QYVDFJYIUQYBNS-VURMDHGXSA-N tert-butyl n-[[4-[(z)-5-bromopent-1-enyl]cyclohexyl]methyl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)CC1CCC(\C=C/CCCBr)CC1 QYVDFJYIUQYBNS-VURMDHGXSA-N 0.000 description 1
- URXMZVNZCVQBRJ-UHFFFAOYSA-N tert-butyl n-methyl-n-[2-[4-(2-oxoethyl)cyclohexyl]ethyl]carbamate Chemical compound CC(C)(C)OC(=O)N(C)CCC1CCC(CC=O)CC1 URXMZVNZCVQBRJ-UHFFFAOYSA-N 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- ZXUCBXRTRRIBSO-UHFFFAOYSA-L tetrabutylazanium;sulfate Chemical compound [O-]S([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC ZXUCBXRTRRIBSO-UHFFFAOYSA-L 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000005309 thioalkoxy group Chemical group 0.000 description 1
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- SEDZOYHHAIAQIW-UHFFFAOYSA-N trimethylsilyl azide Chemical compound C[Si](C)(C)N=[N+]=[N-] SEDZOYHHAIAQIW-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/52—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
- C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01129271 | 2001-12-12 | ||
PCT/EP2002/013786 WO2003053919A1 (en) | 2001-12-12 | 2002-12-05 | Substituted cyclohexane derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20040495A2 true HRP20040495A2 (en) | 2005-06-30 |
Family
ID=8179485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20040495A HRP20040495A2 (en) | 2001-12-12 | 2004-06-01 | Substituted cyclohexane derivatives |
Country Status (26)
Country | Link |
---|---|
US (2) | US6953806B2 (de) |
EP (1) | EP1456171B1 (de) |
JP (1) | JP4124736B2 (de) |
KR (1) | KR20040066896A (de) |
CN (1) | CN100503560C (de) |
AR (1) | AR037774A1 (de) |
AT (1) | ATE348799T1 (de) |
AU (1) | AU2002358096B2 (de) |
BR (1) | BR0214939A (de) |
CA (1) | CA2468879C (de) |
DE (1) | DE60216967T2 (de) |
ES (1) | ES2276974T3 (de) |
GT (1) | GT200200271A (de) |
HR (1) | HRP20040495A2 (de) |
HU (1) | HUP0402262A2 (de) |
IL (1) | IL162104A0 (de) |
MX (1) | MXPA04005550A (de) |
NO (1) | NO20042881L (de) |
PA (1) | PA8560001A1 (de) |
PE (1) | PE20030765A1 (de) |
PL (1) | PL371471A1 (de) |
RU (1) | RU2288221C2 (de) |
TW (1) | TW200409623A (de) |
UY (1) | UY27579A1 (de) |
WO (1) | WO2003053919A1 (de) |
ZA (1) | ZA200404547B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1891002B1 (de) | 2005-06-06 | 2012-05-30 | Merck Sharp & Dohme Limited | Cyclohexansulfonyl-derivate als glyt1-hemmer zur behandlung von schizophrenie |
US8703379B2 (en) * | 2012-07-27 | 2014-04-22 | Xerox Corporation | Chemical binding of renewable oils to polyester emulsion |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2016738A1 (en) * | 1989-06-08 | 1990-12-08 | Philippe Guerry | Substituted aminoalkylbenzene derivatives |
DE4239151A1 (de) | 1992-11-20 | 1994-05-26 | Thomae Gmbh Dr K | N,N-Disubstituierte Arylcycloalkylamine, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung |
TW438774B (en) | 1993-07-14 | 2001-06-07 | Hoffmann La Roche | Pharmaceutical composition for lowering cholesterol containing phenalkylamines and certain novel phenalkylamines |
AU1328197A (en) * | 1995-12-01 | 1997-06-19 | Synaptic Pharmaceutical Corporation | Aryl sulfonamide and sulfamide derivatives and uses thereof |
CA2190699A1 (en) | 1995-12-08 | 1997-06-09 | Johannes Aebi | Tertiary amines |
CA2190708A1 (en) * | 1995-12-08 | 1997-06-09 | Johannes Aebi | Aminoalkyl substituted benzo-heterocyclic compounds |
ES2223170T3 (es) * | 1998-04-29 | 2005-02-16 | Ortho-Mcneil Pharmaceutical, Inc. | Aminotetralinas n sustituidas, ligandos del receptor y y5 del neuropeptido que sirve para el tratamiento de la obesidad y otros trastornos. |
-
2002
- 2002-12-05 ES ES02791779T patent/ES2276974T3/es not_active Expired - Lifetime
- 2002-12-05 KR KR10-2004-7009048A patent/KR20040066896A/ko active IP Right Grant
- 2002-12-05 MX MXPA04005550A patent/MXPA04005550A/es unknown
- 2002-12-05 HU HU0402262A patent/HUP0402262A2/hu unknown
- 2002-12-05 AU AU2002358096A patent/AU2002358096B2/en not_active Ceased
- 2002-12-05 RU RU2004121684/04A patent/RU2288221C2/ru not_active IP Right Cessation
- 2002-12-05 AT AT02791779T patent/ATE348799T1/de not_active IP Right Cessation
- 2002-12-05 EP EP02791779A patent/EP1456171B1/de not_active Expired - Lifetime
- 2002-12-05 CN CNB028249879A patent/CN100503560C/zh not_active Expired - Fee Related
- 2002-12-05 CA CA002468879A patent/CA2468879C/en not_active Expired - Fee Related
- 2002-12-05 WO PCT/EP2002/013786 patent/WO2003053919A1/en active IP Right Grant
- 2002-12-05 JP JP2003554636A patent/JP4124736B2/ja not_active Expired - Fee Related
- 2002-12-05 IL IL16210402A patent/IL162104A0/xx unknown
- 2002-12-05 DE DE60216967T patent/DE60216967T2/de not_active Expired - Lifetime
- 2002-12-05 BR BR0214939-7A patent/BR0214939A/pt not_active IP Right Cessation
- 2002-12-05 PL PL02371471A patent/PL371471A1/xx not_active Application Discontinuation
- 2002-12-06 PA PA20028560001A patent/PA8560001A1/es unknown
- 2002-12-06 TW TW091135415A patent/TW200409623A/zh unknown
- 2002-12-10 AR ARP020104781A patent/AR037774A1/es not_active Application Discontinuation
- 2002-12-10 US US10/315,770 patent/US6953806B2/en not_active Expired - Fee Related
- 2002-12-11 GT GT200200271A patent/GT200200271A/es unknown
- 2002-12-11 PE PE2002001196A patent/PE20030765A1/es not_active Application Discontinuation
- 2002-12-11 UY UY27579A patent/UY27579A1/es not_active Application Discontinuation
-
2004
- 2004-06-01 HR HR20040495A patent/HRP20040495A2/hr not_active Application Discontinuation
- 2004-06-08 ZA ZA200404547A patent/ZA200404547B/en unknown
- 2004-07-07 NO NO20042881A patent/NO20042881L/no not_active Application Discontinuation
-
2005
- 2005-07-07 US US11/176,901 patent/US20050272774A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7442791B2 (en) | Aminoalkylamide substituted cyclohexyl derivatives | |
US6858651B2 (en) | 2,3-oxidosqualene-lanosterol cyclase inhibitors | |
AU2001293744A1 (en) | Novel aminocyclohexane derivatives | |
US20050272774A1 (en) | Substituted cyclohexane derivatives | |
US6965048B2 (en) | Hydroxyalkylamide derivatives | |
JP4339913B2 (ja) | ヒドロキシアルキルアミド類 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20051125 Year of fee payment: 4 |
|
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
OBST | Application withdrawn |